These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2498315)

  • 21. Contribution of phospholipases A2 and D to arachidonic acid liberation and prostaglandin D2 formation with increase in intracellular Ca2+ concentration in rat peritoneal mast cells.
    Ishimoto T; Akiba S; Sato T; Fujii T
    Eur J Biochem; 1994 Jan; 219(1-2):401-6. PubMed ID: 7508386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase inhibitor.
    Lombardo D; Dennis EA
    J Biol Chem; 1985 Jun; 260(12):7234-40. PubMed ID: 3997864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.
    Pfeilschifter J; Schalkwijk C; Briner VA; van den Bosch H
    J Clin Invest; 1993 Nov; 92(5):2516-23. PubMed ID: 8227364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells.
    Balboa MA; Shirai Y; Gaietta G; Ellisman MH; Balsinde J; Dennis EA
    J Biol Chem; 2003 Nov; 278(48):48059-65. PubMed ID: 12963740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.
    Riendeau D; Guay J; Weech PK; Laliberté F; Yergey J; Li C; Desmarais S; Perrier H; Liu S; Nicoll-Griffith D
    J Biol Chem; 1994 Jun; 269(22):15619-24. PubMed ID: 8195210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of manoalide on secreted and intracellular phospholipases.
    Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST
    Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of two phospholipase A2 inhibitors on the neuromuscular blocking activities of homologous phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake.
    Fatehi M; Rowan EG; Harvey AL
    Toxicon; 1995 Dec; 33(12):1633-43. PubMed ID: 8866620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic-AMP inhibits neither A23187-stimulated [14C]-arachidonic acid release from prelabelled lipids nor phospholipase A2 activity in resident rat peritoneal macrophages.
    Weidemann MJ; Arulthilakan JJ; Hunt NH
    Biochem Int; 1990; 20(2):275-85. PubMed ID: 2156507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interference with phospholipase A2 activity reveals mechanistic differences between glucose and glyceraldehyde induced insulin release: implication for coupling of glucose metabolism to phospholipase A2 activity.
    Tadayyon M; Green IC
    Diabete Metab; 1993; 19(1):36-43. PubMed ID: 8504883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoxygenase inhibitors suppress intracellular calcium rise induced by ionomycin in rat thymocytes.
    Gukovskaya AS; Arias Pulido H; Petrunyaka VV; Zinchenko VP; Bezuglov VV
    Cell Calcium; 1990 Sep; 11(8):539-46. PubMed ID: 2124949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.
    Glaser KB; Jacobs RS
    Biochem Pharmacol; 1986 Feb; 35(3):449-53. PubMed ID: 3947381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages.
    Balsinde J; Bianco ID; Ackermann EJ; Conde-Frieboes K; Dennis EA
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8527-31. PubMed ID: 7667324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-Bromophenacyl bromide induces Ca2+ influx in human gingival fibroblasts.
    Ogata Y; Sakurai T; Nakao S; Kuboyama N; Moriwaki K; Furuyama S; Sugiya H
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Mar; 131(3):315-22. PubMed ID: 11912056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eicosanoid production by mouse peritoneal macrophages during Toxoplasma gondii penetration: role of parasite and host cell phospholipases.
    Thardin JF; M'Rini C; Beraud M; Vandaele J; Frisach MF; Bessieres MH; Seguela JP; Pipy B
    Infect Immun; 1993 Apr; 61(4):1432-41. PubMed ID: 8454347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of calcium-dependent phospholipase A2 activity in membrane preparation of rabbit neutrophils. Absence of activation by fMet-Leu-Phe, phorbol 12-myristate 13-acetate and A-kinase.
    Matsumoto T; Tao W; Sha'afi RI
    Biochem J; 1988 Mar; 250(2):343-8. PubMed ID: 3128281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human platelet phospholipase A2 activity by unsaturated fatty acids.
    Ballou LR; Cheung WY
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):371-5. PubMed ID: 3855556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible role of arachidonic acid and of phospholipase A2 in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
    Marone G; Fimiani B; Torella G; Poto S; Bianco P; Condorelli M
    J Clin Lab Immunol; 1983 Oct; 12(2):111-6. PubMed ID: 6644791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
    Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
    Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.